VITRAKVI (LAROTRECTINIB)

**Product type:** Human Prescription Drug

**Active ingredient:** LAROTRECTINIB

**Strength:** 20 mg/mL

**Dosage form:** Solution, Concentrate

**Route:** Oropharyngeal

**Labeler:** Bayer HealthCare Pharmaceuticals Inc.

**Marketing category:** NDA (NDA211710)

**Pharmacologic class:** Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]